217 related articles for article (PubMed ID: 8961273)
1. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
Seol W; Mahon MJ; Lee YK; Moore DD
Mol Endocrinol; 1996 Dec; 10(12):1646-55. PubMed ID: 8961273
[TBL] [Abstract][Full Text] [Related]
2. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
3. Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors.
Downes M; Burke LJ; Bailey PJ; Muscat GE
Nucleic Acids Res; 1996 Nov; 24(22):4379-86. PubMed ID: 8948627
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha.
Burke LJ; Downes M; Laudet V; Muscat GE
Mol Endocrinol; 1998 Feb; 12(2):248-62. PubMed ID: 9482666
[TBL] [Abstract][Full Text] [Related]
5. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
Li H; Leo C; Schroen DJ; Chen JD
Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
[TBL] [Abstract][Full Text] [Related]
6. The nuclear corepressors recognize distinct nuclear receptor complexes.
Cohen RN; Putney A; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
[TBL] [Abstract][Full Text] [Related]
7. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
Tagami T; Lutz WH; Kumar R; Jameson JL
Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
[TBL] [Abstract][Full Text] [Related]
8. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
[TBL] [Abstract][Full Text] [Related]
9. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.
Makowski A; Brzostek S; Cohen RN; Hollenberg AN
Mol Endocrinol; 2003 Feb; 17(2):273-86. PubMed ID: 12554754
[TBL] [Abstract][Full Text] [Related]
10. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
11. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
Loinder K; Söderström M
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):191-6. PubMed ID: 15336696
[TBL] [Abstract][Full Text] [Related]
12. TR surfaces and conformations required to bind nuclear receptor corepressor.
Marimuthu A; Feng W; Tagami T; Nguyen H; Jameson JL; Fletterick RJ; Baxter JD; West BL
Mol Endocrinol; 2002 Feb; 16(2):271-86. PubMed ID: 11818500
[TBL] [Abstract][Full Text] [Related]
13. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
[TBL] [Abstract][Full Text] [Related]
14. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.
Bailey P; Downes M; Lau P; Harris J; Chen SL; Hamamori Y; Sartorelli V; Muscat GE
Mol Endocrinol; 1999 Jul; 13(7):1155-68. PubMed ID: 10406466
[TBL] [Abstract][Full Text] [Related]
15. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs).
Webb P; Anderson CM; Valentine C; Nguyen P; Marimuthu A; West BL; Baxter JD; Kushner PJ
Mol Endocrinol; 2000 Dec; 14(12):1976-85. PubMed ID: 11117528
[TBL] [Abstract][Full Text] [Related]
16. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements.
Cohen RN; Wondisford FE; Hollenberg AN
Mol Endocrinol; 1998 Oct; 12(10):1567-81. PubMed ID: 9773980
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes.
Söderström M; Vo A; Heinzel T; Lavinsky RM; Yang WM; Seto E; Peterson DA; Rosenfeld MG; Glass CK
Mol Endocrinol; 1997 Jun; 11(6):682-92. PubMed ID: 9171232
[TBL] [Abstract][Full Text] [Related]
18. E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode.
Meng X; Webb P; Yang YF; Shuen M; Yousef AF; Baxter JD; Mymryk JS; Walfish PG
Proc Natl Acad Sci U S A; 2005 May; 102(18):6267-72. PubMed ID: 15849266
[TBL] [Abstract][Full Text] [Related]
19. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor.
Hörlein AJ; Näär AM; Heinzel T; Torchia J; Gloss B; Kurokawa R; Ryan A; Kamei Y; Söderström M; Glass CK
Nature; 1995 Oct; 377(6548):397-404. PubMed ID: 7566114
[TBL] [Abstract][Full Text] [Related]
20. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains.
Zamir I; Harding HP; Atkins GB; Hörlein A; Glass CK; Rosenfeld MG; Lazar MA
Mol Cell Biol; 1996 Oct; 16(10):5458-65. PubMed ID: 8816459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
